Franco, F.; Guirado, M.; Martínez-Banaclocha, N.; Gumà, J.; Lavernia, J.; Gómez-Codina, J.; Rodriguez-Abreu, D.; Martínez, F.; Barrajón, E.; Méndez, M.;
et al. Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Curr. Oncol. 2021, 28, 1249-1255.
https://doi.org/10.3390/curroncol28020118
AMA Style
Franco F, Guirado M, Martínez-Banaclocha N, Gumà J, Lavernia J, Gómez-Codina J, Rodriguez-Abreu D, Martínez F, Barrajón E, Méndez M,
et al. Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology. 2021; 28(2):1249-1255.
https://doi.org/10.3390/curroncol28020118
Chicago/Turabian Style
Franco, Fernando, María Guirado, Natividad Martínez-Banaclocha, Josep Gumà, Javier Lavernia, José Gómez-Codina, Delvys Rodriguez-Abreu, Fani Martínez, Enrique Barrajón, Miriam Méndez,
and et al. 2021. "Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)" Current Oncology 28, no. 2: 1249-1255.
https://doi.org/10.3390/curroncol28020118
APA Style
Franco, F., Guirado, M., Martínez-Banaclocha, N., Gumà, J., Lavernia, J., Gómez-Codina, J., Rodriguez-Abreu, D., Martínez, F., Barrajón, E., Méndez, M., Calvo, V., & Provencio, M.
(2021). Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology, 28(2), 1249-1255.
https://doi.org/10.3390/curroncol28020118
